# Evaluation of Foquest in Adults 65 Years and Older With ADHD

> **NCT07710014** · PHASE4 · RECRUITING · sponsor: **Dar Clinical Research Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate hydrochloride extended-release capsules

## Key facts

- **NCT ID:** NCT07710014
- **Lead sponsor:** Dar Clinical Research Inc.
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-06
- **Primary completion:** 2027-07-21
- **Final completion:** 2027-07-21
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710014, "Evaluation of Foquest in Adults 65 Years and Older With ADHD". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07710014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*